ResearcherRoswell Park Comprehensive Cancer CenterNo recent work listed

William G Cance

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0739-8125; OpenAlex author ID A5108625935; NIH RePORTER profile ID 1864010. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 1
Labs led: 1
Collaborators: 2

Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper, 1 grant

Papers 2

Targeting the C-terminal focal adhesion kinase scaffold in pancreatic cancer. Last author DOI 10.1016/j.canlet.2014.07.032 ↗
The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth. Last author DOI 10.18632/oncotarget.1365 ↗

Grants 1

Focal Adhesion Kinase - Tumor Biology and Therapeutics R01CA065910 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Elena Kurenova · 2 shared papers, 2013–2014 · strength 0.08
- Paper Targeting the C-terminal focal adhesion kinase scaffold in pancreatic cancer. DOI 10.1016/j.canlet.2014.07.032 ↗
- Paper The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth. DOI 10.18632/oncotarget.1365 ↗
Priyanka N. Gogate · 1 shared paper, 2014 · strength 0.04
- Paper Targeting the C-terminal focal adhesion kinase scaffold in pancreatic cancer. DOI 10.1016/j.canlet.2014.07.032 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.